PEG-Free Peptide Nanocapsules for mRNA Vaccine Delivery
RSC Pharmaceutics · 2026
DOI: 10.1039/d6pm00147e ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Pharmaceutics, 2026. Verfasst von Nitish Sunil Kunte und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
mRNA vaccines require delivery vectors to protect them from degradation, to improve their cellular uptake and immunogenicity upon administration. Currently, lipid nanoparticles (LNPs) are the only FDA-approved delivery vectors for...
Zitieren
APA
Kunte, N. S., Wall, C., Ribeiro, B. H. L., Noveron-Nunez, J., Schwartz, E., Joshi, S., Hashemi, M., & Avila, A. (2026). PEG-Free Peptide Nanocapsules for mRNA Vaccine Delivery. RSC Pharmaceutics. https://doi.org/10.1039/d6pm00147e
Vancouver
Kunte NS, Wall C, Ribeiro BHL, Noveron-Nunez J, Schwartz E, Joshi S, et al. PEG-Free Peptide Nanocapsules for mRNA Vaccine Delivery. RSC Pharmaceutics. 2026. doi:10.1039/d6pm00147e
BibTeX
@article{Kunte2026,
author = {Kunte, Nitish Sunil and Wall, Collin and Ribeiro, Bruno H. L. and Noveron-Nunez, Jose and Schwartz, Elizabeth and Joshi, Sameer and Hashemi, Mohtadin and Avila, Adriana},
title = {PEG-Free Peptide Nanocapsules for mRNA Vaccine Delivery},
journal = {RSC Pharmaceutics},
year = {2026},
doi = {10.1039/d6pm00147e}
}
EUVIMED